Stock FDBK FEEDBACK PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Feedback plc

Equities

FDBK

GB00BJN59X09

Delayed London S.E.
Other stock markets
 04:02:38 2024-04-29 EDT 		5-day change 1st Jan Change
92 GBX -5.64% Intraday chart for Feedback plc -12.38% +36.30%
03-25 Feedback shares skyrocket on partnership for TB screening in India AN
03-25 Feedback plc, Heal Foundation Team Up for Tuberculosis Screening Projects in India MT

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company's "enterprise value to sales" ratio is among the highest in the world.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
FEEDBACK PLC Stock Feedback plc
+36.30% 16.19M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.94% 32.47B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+16.51% 7.45B
C-
SECTRA AB Stock Sectra AB
+21.49% 3.89B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-15.12% 3.17B
C-
OMNICELL, INC. Stock Omnicell, Inc.
-25.90% 1.28B
B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B -
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+0.49% 893M
C
VERADIGM INC. Stock Veradigm Inc.
-25.64% 857M -
C+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. FDBK Stock
  4. Ratings Feedback plc